key: cord-1032808-txe3beav
authors: Alberca, Gabriela Gama Freire; Alberca, Ricardo Wesley
title: What is the long‐term clinical significance of anti‐SARS‐CoV‐2‐specific IgG?
date: 2020-11-01
journal: Influenza Other Respir Viruses
DOI: 10.1111/irv.12825
sha: 7c5246194fbfc585172c3a6a7b9e809d1647bf6a
doc_id: 1032808
cord_uid: txe3beav

nan

To the Editor:

We read with great interest the article "Clinical significance of SARS-CoV-2-specific IgG detection with a rapid antibody kit for COVID-19 patients" by Chong The ability to prevent the re-infection of anti-SARS-CoV-2 IgG produced after a natural infection by SARS-CoV-2 is yet to be determined. Therefore, we hypothesize that the severity of the initial infection may influence the anti-SARS-CoV-2 antibody production and its viral elimination efficacy.

In addition, a few confirmed cases of re-infection have been reported. [10] [11] [12] The two main hypotheses would be a mutation or 

The authors declare that they have no conflicts of interest. The peer review history for this article is available at https://publo ns.com/publo n/10.1111/irv.12825.

The data that support the findings of this study are available in the referenced material of this article. 

Clinical significance of SARS-CoV-2-specific IgG detection with a rapid antibody kit for COVID-19 patients

Distinct features of SARS-CoV-2-specific IgA response in COVID-19 patients

Dynamics of anti-SARS-Cov-2 IgM and IgG antibodies among COVID-19 patients

Antibody responses to SARS-CoV-2 in patients with COVID-19

One case of coronavirus disease 2019 (COVID-19) in a patient co-infected by HIV with a low CD4+ T-cell count

A human monoclonal antibody blocking SARS-CoV-2 infection

Human neutralizing antibodies elicited by SARS-CoV-2 infection

SARS-CoV-2 environmental contamination associated with persistently infected COVID-19 patients

Neutralizing antibody production in asymptomatic and mild COVID-19 patients, in comparison with pneumonic COVID-19 patients

COVID-19 re-infection by a phylogenetically distinct SARS-coronavirus-2 strain confirmed by whole genome sequencing

A case of early re-infection with SARS-CoV-2

Case report: recurrent clinical symptoms of COVID-19 in healthcare professionals: a series of cases from Brazil

Rapid decay of Anti-SARS-CoV-2 antibodies in persons with mild Covid-19

Longitudinal analysis of severe acute respiratory syndrome (SARS) coronavirus-specific antibody in SARS patients

Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses